TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Long-Acting Reversible Contraception: New Research to Reduce Unintended Pregnancy
Brief Summary: In the proposed study, women aged 18-29 seeking oral or injectable contraception will be offered an opportunity to try LARC instead; the FDA-approved options include two types of intrauterine products and one type of subdermal contraceptive implant. Over a 24 month period, the experiences of LARC users will be compared to the experiences of those opting for their initial short-acting method.


Options:
A: Arm Label: Immediate Postplacental; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Arm Label: Early Postpartum; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Arm Label: Interval; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Intervention Type: DEVICE; Name: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer); Assigned to Arm(s): Early Postpartum, Immediate Postplacental, Interval
B: Arm Label: Preference SARC; Type: OTHER; Interventions: Drug: DMPA, Drug: oral contraceptives | Arm Label: Randomized LARC; Type: EXPERIMENTAL; Interventions: Drug: Implanon®, Drug: ParaGard®, Drug: Mirena® | Arm Label: Randomized SARC; Type: ACTIVE_COMPARATOR; Interventions: Drug: DMPA, Drug: oral contraceptives | Intervention Type: DRUG; Name: DMPA; Assigned to Arm(s): Preference SARC, Randomized SARC | Intervention Type: DRUG; Name: oral contraceptives; Assigned to Arm(s): Preference SARC, Randomized SARC | Intervention Type: DRUG; Name: Implanon®; Assigned to Arm(s): Randomized LARC | Intervention Type: DRUG; Name: ParaGard®; Assigned to Arm(s): Randomized LARC | Intervention Type: DRUG; Name: Mirena®; Assigned to Arm(s): Randomized LARC
C: Arm Label: PostPlacental IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T intrauterine device | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Copper T intrauterine device; Assigned to Arm(s): PostPlacental IUD insertion
D: Arm Label: early insertion; Type: EXPERIMENTAL; Interventions: Drug: early insertion | Arm Label: conventional insertion; Type: ACTIVE_COMPARATOR; Interventions: Drug: conventional insertion | Intervention Type: DRUG; Name: early insertion; Assigned to Arm(s): early insertion | Intervention Type: DRUG; Name: conventional insertion; Assigned to Arm(s): conventional insertion

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis
Brief Summary: The investigators hypothesise that long term statin treatment will improve patients' symptoms through its anti-inflammatory effect. The beneficial effects on patient symptoms (cough, sputum volume, bacterial load, airway function, exercise tolerance, exacerbation frequency and health related quality of life) will be consequent on reduced neutrophilic airways inflammation.


Options:
A: Arm Label: Mannitol; Type: EXPERIMENTAL; Interventions: Drug: Inhaled mannitol | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Matched control | Intervention Type: DRUG; Name: Inhaled mannitol; Assigned to Arm(s): Mannitol | Intervention Type: DRUG; Name: Matched control; Assigned to Arm(s): Control
B: Arm Label: AZLI-AZLI; Type: EXPERIMENTAL; Interventions: Drug: AZLI | Arm Label: Placebo-AZLI; Type: PLACEBO_COMPARATOR; Interventions: Drug: AZLI, Drug: Placebo | Intervention Type: DRUG; Name: AZLI; Assigned to Arm(s): AZLI-AZLI, Placebo-AZLI | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo-AZLI
C: Arm Label: Atorvastatin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atorvastatin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Atorvastatin | Intervention Type: DRUG; Name: Atorvastatin; Assigned to Arm(s): Atorvastatin, Placebo
D: Arm Label: AZLI-AZLI; Type: EXPERIMENTAL; Interventions: Drug: AZLI | Arm Label: Placebo-AZLI; Type: PLACEBO_COMPARATOR; Interventions: Drug: AZLI, Drug: Placebo | Intervention Type: DRUG; Name: AZLI; Assigned to Arm(s): AZLI-AZLI, Placebo-AZLI | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo-AZLI

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Vaginal Dilators for Prevention of De Novo Dyspareunia After Prolapse Surgery: A Randomized Controlled Trial
Brief Summary: This is a randomized clinical trial comparing rates of de novo dyspareunia in women with and without vaginal dilator use following surgery for pelvic organ prolapse with traditional posterior repair. Our hypothesis is daily use of vaginal dilators from post-op week 4 through week 8 after posterior repair will reduce the rate of de novo dyspareunia.


Options:
A: Arm Label: No dilator use; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Dilator use; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dilator use | Intervention Type: BEHAVIORAL; Name: Dilator use; Assigned to Arm(s): Dilator use
B: Arm Label: IV Acetaminophen; Type: EXPERIMENTAL; Interventions: Drug: IV Acetaminophen | Arm Label: Saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: IV Acetaminophen | Intervention Type: DRUG; Name: IV Acetaminophen; Assigned to Arm(s): IV Acetaminophen, Saline
C: Arm Label: Dexamethasone; Type: EXPERIMENTAL; Interventions: Drug: Dexamethasone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Dexamethasone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Group A; Type: ACTIVE_COMPARATOR; Interventions: Other: No bowel prep | Arm Label: Group B; Type: ACTIVE_COMPARATOR; Interventions: Other: Clear liquid diet and 2 Fleet's enemas | Intervention Type: OTHER; Name: No bowel prep; Assigned to Arm(s): Group A | Intervention Type: OTHER; Name: Clear liquid diet and 2 Fleet's enemas; Assigned to Arm(s): Group B

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Systems Intervention to Promote Colorectal Cancer Screening/ Program for the Elimination of Cancer Disparities
Brief Summary: Colorectal cancer is the second leading cause of cancer death and one of the most commonly diagnosed malignancies. Screening is effective at reducing incidence and mortality from colorectal cancer. This study will evaluate the effectiveness of implementing systems-changes in community health centers that facilitate screening.


Options:
A: Arm Label: Enhanced usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: ED-only; Type: EXPERIMENTAL; Interventions: Behavioral: CAPE | Arm Label: ED-plus-home; Type: EXPERIMENTAL; Interventions: Behavioral: CAPE, Behavioral: CHW home visits | Intervention Type: BEHAVIORAL; Name: CAPE; Assigned to Arm(s): ED-only, ED-plus-home | Intervention Type: BEHAVIORAL; Name: CHW home visits; Assigned to Arm(s): ED-plus-home
B: Arm Label: Interventional; Type: EXPERIMENTAL; Interventions: Other: Systems-level intervention to promote colon cancer screening | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Systems-level intervention to promote colon cancer screening; Assigned to Arm(s): Interventional
C: Arm Label: Arm 1; Type: OTHER; Interventions: Procedure: System level depression care quality improvement | Intervention Type: PROCEDURE; Name: System level depression care quality improvement; Assigned to Arm(s): Arm 1
D: Arm Label: Technology supported supervision; Type: EXPERIMENTAL; Interventions: Other: Technology supported supervision, Other: Integrated community case management | Arm Label: Community supported supervision; Type: EXPERIMENTAL; Interventions: Behavioral: Community supported supervision, Other: Integrated community case management | Arm Label: Control arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Integrated community case management | Intervention Type: OTHER; Name: Technology supported supervision; Assigned to Arm(s): Technology supported supervision | Intervention Type: BEHAVIORAL; Name: Community supported supervision; Assigned to Arm(s): Community supported supervision | Intervention Type: OTHER; Name: Integrated community case management; Assigned to Arm(s): Community supported supervision, Control arm, Technology supported supervision

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Preventing Cognitive Decline in African Americans With Mild Cognitive Impairment
Brief Summary: The goal of this study is to determine whether increasing participation in cognitive, physical, and/or social activities prevents cognitive decline in older African Americans (AAs) with Mild Cognitive Impairment (MCI). Patients with MCI are at increased risk for Alzheimer's Disease (AD); we propose that increasing participation in activities will prevent cognitive decline and may delay the onset of Alzheimer's Disease (AD). We will test this hypothesis by conducting a clinical trial in which older AAs with MCI (aged 65 years and older) will be randomized to Behavior Activation (BA) (a behavioral intervention that increases participation in daily activities) or Supportive Therapy (ST) (a person-centered psychotherapy that involves active listening and offering support focusing on participants' problems and concerns). We hypothesize that BA-treated subjects will have fewer declines in cognitive and functional abilities, fewer depressive and neuropsychiatric symptoms, and better quality of life than ST-treated subjects at 24 months.


Options:
A: Intervention Type: BEHAVIORAL; Name: support groups; Assigned to Arm(s): N/A
B: Arm Label: Behavior Activation; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Activation (BA) | Arm Label: Supportive Therapy (ST); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Supportive Therapy (ST) | Intervention Type: BEHAVIORAL; Name: Behavioral Activation (BA); Assigned to Arm(s): Behavior Activation | Intervention Type: BEHAVIORAL; Name: Supportive Therapy (ST); Assigned to Arm(s): Supportive Therapy (ST)
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Activity matched to interest | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Activity matched to function | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Activity matched to both interest and function | Arm Label: 4; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Activity matched to interest; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Activity matched to function; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Activity matched to both interest and function; Assigned to Arm(s): 3
D: Arm Label: 1 Problem Solving Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Problem Solving Therapy | Arm Label: 2 Brief Supportive Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Brief Supportive Therapy | Intervention Type: BEHAVIORAL; Name: Problem Solving Therapy; Assigned to Arm(s): 1 Problem Solving Therapy | Intervention Type: BEHAVIORAL; Name: Brief Supportive Therapy; Assigned to Arm(s): 2 Brief Supportive Therapy

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Type 2 Diabetes Peer Counseling on Behavioral, Metabolic, and Health Outcomes Among Latinos
Brief Summary: The objectives of this study are:

* To develop a comprehensive culturally tailored model of diabetes management that integrates the work of community-based peer counselors and clinical specialists into a multi-disciplinary health care team serving the Latino community.
* To implement an intervention that provides education and support to Latino adults diagnosed with Type 2 diabetes in both clinical and home settings.
* To evaluate this intervention for its impact on program adherence, and improved outcomes sustained over time as reflected by metabolic, clinical, cognitive and behavioral measures.


Options:
A: Arm Label: behavioral intervention, counseling; Type: EXPERIMENTAL; Interventions: Behavioral: culturally tailored diabetes education | Arm Label: delyed intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: culturally tailored diabetes education; Assigned to Arm(s): behavioral intervention, counseling
B: Arm Label: Shed-Meds: A Patient-Centered Deprescribing Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Shed-Meds: A Patient-Centered Deprescribing Intervention | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Shed-Meds: A Patient-Centered Deprescribing Intervention; Assigned to Arm(s): Shed-Meds: A Patient-Centered Deprescribing Intervention
C: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Diabetes Peer Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes Peer Counseling | Intervention Type: BEHAVIORAL; Name: Diabetes Peer Counseling; Assigned to Arm(s): Diabetes Peer Counseling
D: Arm Label: Systematic nurse-led GA; Type: EXPERIMENTAL; Interventions: Other: health care organization | Arm Label: GP-led GA on a case-by-case basis, as decided by the GP; Type: EXPERIMENTAL; Interventions: Other: health care organization | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: health care organization; Assigned to Arm(s): GP-led GA on a case-by-case basis, as decided by the GP, Systematic nurse-led GA

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Type 2 Diabetes Peer Counseling on Behavioral, Metabolic, and Health Outcomes Among Latinos
Brief Summary: The objectives of this study are:

* To develop a comprehensive culturally tailored model of diabetes management that integrates the work of community-based peer counselors and clinical specialists into a multi-disciplinary health care team serving the Latino community.
* To implement an intervention that provides education and support to Latino adults diagnosed with Type 2 diabetes in both clinical and home settings.
* To evaluate this intervention for its impact on program adherence, and improved outcomes sustained over time as reflected by metabolic, clinical, cognitive and behavioral measures.


Options:
A: Arm Label: Technology-based self-management model; Type: EXPERIMENTAL; Interventions: Device: Technology-based self-management model | Arm Label: Conventional self-management; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Technology-based self-management model; Assigned to Arm(s): Technology-based self-management model
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Group based non-pharmacological rehabilitation | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Individual non-pharmacological rehabilitation | Intervention Type: BEHAVIORAL; Name: Group based non-pharmacological rehabilitation; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Individual non-pharmacological rehabilitation; Assigned to Arm(s): 2
C: Arm Label: Telecare; Type: EXPERIMENTAL; Interventions: Other: Telecare | Arm Label: Conventional therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional therapy | Intervention Type: OTHER; Name: Telecare; Assigned to Arm(s): Telecare | Intervention Type: OTHER; Name: Conventional therapy; Assigned to Arm(s): Conventional therapy
D: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Diabetes Peer Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes Peer Counseling | Intervention Type: BEHAVIORAL; Name: Diabetes Peer Counseling; Assigned to Arm(s): Diabetes Peer Counseling

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stress Reduction and Cardiovascular Disease Morbidity and Mortality
Brief Summary: This randomized controlled clinical trial tests the hypothesis that a selected stress reduction approach, the Transcendental Meditation program will reduce all-cause mortality, myocardial infarction and stroke in African American patients with coronary heart disease. Secondary hypotheses include effects on other cardiovascular clinical events, blood pressure and psychosocial stress.


Options:
A: Arm Label: Community-based nurse care management; Type: EXPERIMENTAL; Interventions: Other: Community-based nurse care management | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Community-based nurse care management; Assigned to Arm(s): Community-based nurse care management
B: Arm Label: Stress reduction; Type: EXPERIMENTAL; Interventions: Behavioral: Transcendental Meditation | Arm Label: health education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health Education | Intervention Type: BEHAVIORAL; Name: Transcendental Meditation; Assigned to Arm(s): Stress reduction | Intervention Type: BEHAVIORAL; Name: Health Education; Assigned to Arm(s): health education
C: Arm Label: conventional; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: structured; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: education | Intervention Type: BEHAVIORAL; Name: education; Assigned to Arm(s): structured
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: education | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: education; Assigned to Arm(s): A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stress Reduction and Cardiovascular Disease Morbidity and Mortality
Brief Summary: This randomized controlled clinical trial tests the hypothesis that a selected stress reduction approach, the Transcendental Meditation program will reduce all-cause mortality, myocardial infarction and stroke in African American patients with coronary heart disease. Secondary hypotheses include effects on other cardiovascular clinical events, blood pressure and psychosocial stress.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Minimal behavioral intervention | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control intervention | Intervention Type: BEHAVIORAL; Name: Minimal behavioral intervention; Assigned to Arm(s): Intervention group | Intervention Type: BEHAVIORAL; Name: Control intervention; Assigned to Arm(s): Control group
B: Arm Label: Internet-based CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based CBT | Arm Label: Treatment as usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Internet-based CBT; Assigned to Arm(s): Internet-based CBT
C: Intervention Type: BEHAVIORAL; Name: multifactorial continued educational - behavioural programme; Assigned to Arm(s): N/A
D: Arm Label: Stress reduction; Type: EXPERIMENTAL; Interventions: Behavioral: Transcendental Meditation | Arm Label: health education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health Education | Intervention Type: BEHAVIORAL; Name: Transcendental Meditation; Assigned to Arm(s): Stress reduction | Intervention Type: BEHAVIORAL; Name: Health Education; Assigned to Arm(s): health education

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stress Reduction and Cardiovascular Disease Morbidity and Mortality
Brief Summary: This randomized controlled clinical trial tests the hypothesis that a selected stress reduction approach, the Transcendental Meditation program will reduce all-cause mortality, myocardial infarction and stroke in African American patients with coronary heart disease. Secondary hypotheses include effects on other cardiovascular clinical events, blood pressure and psychosocial stress.


Options:
A: Arm Label: Distress management; Type: EXPERIMENTAL; Interventions: Behavioral: A cognitive behavior therapy distress management program targeting wellbeing in patients with atrial fibrillation and their relatives | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: A cognitive behavior therapy distress management program targeting wellbeing in patients with atrial fibrillation and their relatives; Assigned to Arm(s): Distress management
B: Arm Label: Mindfulness; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-based intervention | Arm Label: Sham meditation; Type: SHAM_COMPARATOR; Interventions: Behavioral: Sham meditation | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness-based intervention; Assigned to Arm(s): Mindfulness | Intervention Type: BEHAVIORAL; Name: Sham meditation; Assigned to Arm(s): Sham meditation
C: Arm Label: Mindfulness-based Addiction Treatment (MBAT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mindfulness-based Addiction Treatment, Behavioral: Self-Help guide, Drug: Nicotine Patch | Arm Label: iQuit Mindfully; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-based Addiction Treatment, Behavioral: iQuit Mindfully, Behavioral: Self-Help guide, Drug: Nicotine Patch | Intervention Type: BEHAVIORAL; Name: Mindfulness-based Addiction Treatment; Assigned to Arm(s): Mindfulness-based Addiction Treatment (MBAT), iQuit Mindfully | Intervention Type: BEHAVIORAL; Name: iQuit Mindfully; Assigned to Arm(s): iQuit Mindfully | Intervention Type: BEHAVIORAL; Name: Self-Help guide; Assigned to Arm(s): Mindfulness-based Addiction Treatment (MBAT), iQuit Mindfully | Intervention Type: DRUG; Name: Nicotine Patch; Assigned to Arm(s): Mindfulness-based Addiction Treatment (MBAT), iQuit Mindfully
D: Arm Label: Stress reduction; Type: EXPERIMENTAL; Interventions: Behavioral: Transcendental Meditation | Arm Label: health education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health Education | Intervention Type: BEHAVIORAL; Name: Transcendental Meditation; Assigned to Arm(s): Stress reduction | Intervention Type: BEHAVIORAL; Name: Health Education; Assigned to Arm(s): health education

Answer: D